Britannia Life Sciences Income Statement

Financials in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Revenue	7.19	7.57	6.4	7.3	1.42	-
Revenue Growth (YoY)	-3.93%	18.20%	-12.28%	412.42%	-	-
Cost of Revenue	2.98	2.72	1.77	2.04	0.25	-
Gross Profit	4.22	4.85	4.64	5.26	1.18	-
Selling, General & Admin	3.33	3.34	2.59	2.54	0.79	0.63
Other Operating Expenses	-	-	-	-	0.1	-
Operating Expenses	3.33	3.57	3.64	3.65	0.89	0.63
Operating Income	0.89	1.29	0.99	1.62	0.29	-0.63
Interest Expense	-1.19	-1.28	-0.85	-2.31	-0.36	-
Earnings From Equity Investments	-1.76	-0.96	-0.02	-0	-	-
Currency Exchange Gain (Loss)	-0.59	-0.11	-0.06	0.61	0.19	-
Other Non Operating Income (Expenses)	-5.18	-3.82	4.41	-3.22	0.29	-
EBT Excluding Unusual Items	-7.84	-4.89	4.47	-3.3	0.41	-0.63
Impairment of Goodwill	-0.04	-0.04	-	-	-	-
Gain (Loss) on Sale of Assets	0.25	0.47	1.39	-	-	-
Other Unusual Items	-	-	-	-9.97	-0.01	-
Pretax Income	-7.62	-4.47	5.86	-13.27	0.4	-0.63
Income Tax Expense	-0.21	-0.07	0.02	0.71	0.26	-
Earnings From Continuing Operations	-7.42	-4.4	5.84	-13.99	0.14	-0.63
Minority Interest in Earnings	-0.56	-0.37	-0.75	-1.47	-0.3	-
Net Income	-7.98	-4.77	5.08	-15.46	-0.16	-0.63
Net Income to Common	-7.98	-4.77	5.08	-15.46	-0.16	-0.63
Shares Outstanding (Basic)	162	162	162	110	78	6
Shares Outstanding (Diluted)	162	162	162	110	78	6
Shares Change (YoY)	-0.05%	0.07%	48.07%	41.06%	1138.06%	-
EPS (Basic)	-0.05	-0.03	0.03	-0.14	-0.00	-0.10
EPS (Diluted)	-0.05	-0.03	0.03	-0.14	-0.00	-0.10
Free Cash Flow	1.09	1.96	1.95	2.71	-0.54	-0.5
Free Cash Flow Per Share	0.01	0.01	0.01	0.03	-0.01	-0.08
Gross Margin	58.63%	64.12%	72.43%	72.08%	82.64%	-
Operating Margin	12.38%	17.01%	15.52%	22.13%	20.23%	-
Profit Margin	-110.97%	-62.99%	79.39%	-211.76%	-11.03%	-
Free Cash Flow Margin	15.10%	25.85%	30.50%	37.16%	-38.15%	-
EBITDA	0.89	1.41	1.1	1.75	0.32	-
EBITDA Margin	12.31%	18.64%	17.25%	24.02%	22.24%	-
D&A For EBITDA	-0.01	0.12	0.11	0.14	0.03	-
EBIT	0.89	1.29	0.99	1.62	0.29	-0.63
EBIT Margin	12.38%	17.01%	15.52%	22.13%	20.23%	-
Effective Tax Rate	-	-	0.34%	-	64.31%	-

Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.